J. Kermit Anderson's most recent trade in Adial Pharmaceuticals Inc was a trade of 28,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adial Pharmaceuticals Inc | J. Kermit Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | J. Kermit Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | J. Kermit Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharmaceuticals Inc | J. Kermit Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 40,000 | 40,000 | - | - | Stock Option | |
| Adial Pharmaceuticals Inc | J. Kermit Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option |